We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Automating Blood Smears Developed for Easier Malaria Diagnosis

By LabMedica International staff writers
Posted on 03 Feb 2022
Blood smears are used in diagnosis for a variety of hematological disorders, such as anemia and leukemia. More...
They are also the preferred method of diagnosis of parasitic infections, such as malaria and filariasis in developing world laboratories.

The current “gold standard” for malaria diagnosis is by optical microscopy examination of blood smears. A thin film of the patients’ bloods is fixed onto a microscope slide and stained. The microscopists look at the smear, counting the parasites in various fields of view. These experts can establish the species of malaria and parasite density.

Bioengineers at Cambridge University (Cambridge, UK) collaborating with their colleagues in Tanzania and the UK created a series of devices, which they call “autohaem.” Autohaem devices aim at enabling even non-experts to produce consistent, high quality, thin film blood smears at low cost. The autohaem devices, solves this problem by automating the smearing process so every smear is correct and consistent. The devices come in two varieties, the autohaem smear and the autohaem smear+, the latter of which is fully automated with a motorized smearing mechanism. In tests, inexperienced technicians were able to use the device to produce expert-quality smears.

A key goal of the project was to make the devices accessible to as many people as possible, so the scientists designed their devices to be easy to build, using readily available or 3D-printed components. A pipeline for automated analysis of smear quality was presented and used for device optimization. Red Blood Cells (RBCs), at the typical hematocrit for malaria investigations, are used as the testing media. This pipeline will also be suitable for a more systematic analysis of blood smear preparation, for example, to help with training and evaluation of technicians.

Samuel McDermott, PhD, the senior author of the study, said, “Creating blood smears is a laborious, repetitive task that requires an expert level of skill and manual dexterity. By using automated blood smearing machines, such as autohaem devices, technicians will be able to increase their throughput while maintaining a high enough quality for diagnosis. In some countries, up to 81.5% of blood smears are prepared incorrectly. If a blood smear is prepared incorrectly, when examined under a microscope, the technician will struggle to make a correct diagnosis. Because these smears are often made in a rural clinic and sent to a regional facility for examination, any issues in the smear could cause days of delay.”

The authors concluded that they have developed and presented the autohaem range of devices for automated blood smearing. Autohaem smear is a mechanical device, and autohaem smear+ is an electro-mechanical device. The devices are designed to be sustainable and all the designs and assembly instructions are available under an open source license. The study was published on January 18, 2022, in the journal Review of Scientific Instruments.

Related Links:
Cambridge University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Drug Testing Assays
Atellica DT 250 Analyzer
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Guardant Health has introduced new applications for Guardant360 Liquid, expanding the test’s capabilities for treatment selection in breast and lung cancers. (Photo courtesy of Guardant Health)

Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations

Treatment selection in advanced breast and lung cancers can be challenging when traditional biomarkers are absent and genomic findings alone do not fully clarify which therapies may be effective.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.